Team
The Pataigin team has extensive experience and expertise in diagnostics businesses, microbial assays, and clinical mass spectrometry.

Erik Nilsson
CEO
- Experienced leader of biotech and hi-tech companies.
- Prior CEO roles: Rosetta@Cloud (computational biology), Insilicos (cardio diagnostic), Deurion (mass spectrometry), GraphiCode (industrial automation).

Prof. Robert Ernst
VP Microbiology
- Co-inventor of BACLIB.
- Recognized leader in microbial lipid analysis.
- Expert on lipid A biology.

Prof. David Goodlett
VP Analytical Chemistry
- Co-inventor of BACLIB.
- Acclaimed innovator in mass spectrometry.
- Formerly at Johnson & Johnson, BMS.

Dr. Michael Chen
VP Medicine, CMO
- Medical Director and licensed physician in Canada.
- Expert and leader in clinical chemistry and laboratory medicine.
- Clinician scientist in translational mass spectrometry.

Matthew Sorensen
Director of Development
- Inventor of FLAT BACLIB extraction method.
- Architect of Pataigin’s computational identification system.
- Multiple patents pending.

Dr. Ian Sanders
Advisor
- Multiple senior roles in global life science enterprises.
- Experienced mass spectrometry scientist and executive.
- Former President, Bruker Life Science. Former CEO, ToxiMet.

Deborah Elvins
Advisor
- Retired lawyer, biotech executive.
- Former VP Legal Affairs, Dendreon.
- Former Acting General Counsel, Cascadian Therapeutics.